Lymphatic function, lymphangiogenesis, and cancer metastasis

Microscopy Research and Technique

Volumn 55, Issue 2, 2001, Pages 92-99

  Swartz, Melody A ^a   Skobe, Mihaela ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Lymphangiogenesis; Lymphatic function; Lymphatic metastasis; VEGF C; VEGF D

Indexed keywords

CELL ENGINEERING; DISEASES; ENDOTHELIAL CELLS; PATHOLOGY;

CANCER; CANCER METASTASIS; LYMPH NODE; LYMPHANGIOGENESIS; LYMPHATIC FUNCTIONS; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; TUMOR METASTASIS; VEGF-C; VEGF-D;

TUMORS;

ARTICLE; BIOGENESIS; CANCER INVASION; HUMAN; LYMPH FLOW; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPH VESSEL ENDOTHELIUM; LYMPHATIC SYSTEM; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; TUMOR GROWTH; ULTRASTRUCTURE;

EID: 0035887043     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jemt.1160     Document Type: Article

References (96)

1. Achen MG, Jeltsch M, Kukk E, Makinen T, Vitali A, Wilks AF, Alitalo K, Stacker SA. 1998. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (FLT-4). Proc Natl Acad Sci USA 95:548-553.
2. Akagi K, Ikeda Y, Miyazaki M, Abe T, Kinoshita J, Maehara Y, Sugimachi K. 2000. Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br J Cancer 83:887-891.
3. Andre T, Kotelevets L, Vaillant JC, Coudray AM, Weber L, Prevot S, Parc R, Gespach C, Chastre E. 2000. VEGF, VEGF-B, VEGF-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa. Int J Cancer 86:174-181.
4. Aukland K, Nicolaysen G. 1981. Interstitial fluid volume: local regulatory mechanisms. Physiol Rev 61:556-643.
5. Aukland K, Reed RK. 1993. Interstitial-lymphatic mechanisms in the control of extracellular fluid volume. Physiol Rev 73:1-78.
6. Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R, Jones M, Jackson DG. 1999. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144:789-801.
7. Bates DO, Levick JR, Mortimer PS. 1994. Starling pressures in the human arm and their alteration in postmastectomy oedema. J Physiol (Lond) 477:355-363.
8. Berk DA, Swartz MA, Leu AJ, Jain RK. 1996. Transport in lymphatic capillaries. II. Microscopic velocity measurement with fluorescence recovery after photobleaching. Am J Physiol 270:H330-337.
9. Bert JL, Bowen BD, Reed RK. 1988. Microvascular exchange and interstitial volume regulation in the rat: model validation. Am J Physiol 254:H384-399.
10. Bollinger A, Jäger K, Sgier F, Seglias J. 1981. Fluorescence microlymphangiography. Circulation 64:1195-1200.
11. Breiteneder-Geleff S, Soleiman A, Kowalski H, Horvat R, Amann G, Kriehuber E, Diem K, Weninger W, Tschachler E, Alitalo K, Kerjaschki D. 1999. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 154:385-394.
12. Bunone G, Vigneri P, Mariani L, Buto S, Collini P, Pilotti S, Pierotti MA, Bongarzone I. 1999. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features. Am J Pathol 155:1967-1976.
13. Carmeliet P, Jain RK. 2000. Angiogenesis in cancer and other diseases. Nature 407:249-257.
14. Casley-Smith JR, Florey HW. 1961. The structure of normal small lymphatics. Q J Exp Physiol 46:101.
15. Colantuoni A, Bertuglia S, Intaglietta M. 1984. Effects of anesthesia on the spontaneous activity of the microvasculature. Int J Microcirc Clin Exp 3:13-28.
16. Cornford ME, Oldendorf WH. 1993. Terminal endothelial cells of lymph capillaries as active transport structures involved in the formation of lymph in rat skin. Lymphology 26:67-78.
17. Daroczy J. 1988. The dermal lymphatic capillaries. Berlin, Heidelberg: Springer-Verlag.
18. Eggert A, Ikegaki N, Kwiatkowski J, Zhao H, Brodeur GM, Himelstein BP. 2000. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Clin Cancer Res 6:1900-1908.
19. Evans HM. 1908. On the occurrence of newly-formed lymphatic vessels in malignant growths. Johns Hopkins Med J 19:232.
20. Fellmer PT, Sato K, Tanaka R, Okamoto T, Kato Y, Kobayashi M, Shibuya M, Obara T. 1999. Vascular endothelial growth factor-C gene expression in papillary and follicular thyroid carcinomas. Surgery 126:1056-1061.
21. Fischer M, Herrig I, Costanzo U, Wen S, Schiesser M, Franzeck UK, Hoffmann U, Bollinger A. 1994. Flow velocity in single lymphatic human skin capillaries of healthy controls. Rome: 18th Annual European Conference on Microcirculation.
22. Fisher B, Fisher ER. 1968. Role of the lymphatic system in dissemination of tumor. In: Mayerson HS, editor. Lymph and the lymphatic system. Springfield, IL: Charles C. Thomas, p 324.
23. Folkman J. 1996. Angiogenesis and tumor growth. N Engl J Med 334:921.
24. Gerli R, Ibba L, Fruschelli C. 1990. A fibrillar elastic apparatus around human lymph capillaries. Anat Embryol 181:281-286.
25. Gerli R, Ibba L, Fruschelli C. 1991. Ultrastructural cytochemistry of anchoring filaments of human lymphatic capillaries and their relation to elastic fibers. Lymphology 24:105-112.
26. Gilchrist RK. 1950. Surgical management of advanced cancer of the breast. Arch Surg 61:913-929.
27. Guyton AC. 1965. Pressure-volume relationships in the interstitial spaces. Invest Ophthalmol 4:1075-1084.
28. Hall JG, Morris B, Woolley G. 1965. Intrinsic rhythmic propulsion of lymph in the unanesthetized sheep. J Physiol Lond 180:336-349.
29. Hanahan D. 1985. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 315:115-22.
30. Hargens AR, Zweifach BW. 1977. Contractile stimuli in collecting lymph vessels. Am J Physiol 233:H57-H65.
31. Hogan RD, Unthank JL. 1986. The initial lymphatics as sensors of interstitial fluid volume. Microvasc Res 31:317-324.
32. Ikomi F, Schmid-Schönbein GW. 1996. Lymph pump mechanics in the rabbit hind leg. Am J Physiol 271:H173-183.
33. Jain RK. 1987. Transport of molecules in the tumor interstitium: a review. Cancer Res 47:3039-3051.
34. Jeltsch M, Kaipainen A, Joukov V, Kukk E, Lymbousssaki A, Lakso M, Alitalo K. 1997. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276:1423-1425.
35. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K. 1996. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15:1751.
36. Joukov V, Sorsa T, Kumar V, Jeltsch M, Claesson WL, Cao Y, Saksela O, Kalkkinen N, Alitalo K. 1997. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J 16:3898-3911.
37. Jussila L, Valtola R, Partanen TA, Salven P, Heikkila P, Matikainen MT, Renkonen R, Kaipainen A, Detmar M, Tschachler E, Alitalo R, Alitalo K. 1998. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res 58:1599-1604.
38. Kaipainen A, Korhonen J, Mustonen T, van HV, Fang GH, Dumont D, Breitman M, Alitalo K. 1995. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92:3566-3570.
39. Kurebayashi J, Otsuki T, Kunisue H, Mikami Y, Tanaka K, Yamamoto S, Sonoo H. 1999. Expression of vascular endothelial growth factor (VEGF) family members in breast cancer. Jpn J Cancer Res 90:977-981.
40. Lauweryns JM, Baert J, de Loecker W. 1976. Fine filaments in lymphatic endothelial cells. J Cell Biol 68:163-167.
41. Leak LV. 1970. Electron microscopic observations on lymphatic capillaries and the structural components of the connective tissue-lymph interface. Microvasc Res 2:361-391.
42. Leak LV. 1976. The structure of lymphatic capillaries in lymph formation. Fed Proc 35:1863-1871.
43. Leak LV, Burke JF. 1966. Fine structure of the lymphatic capillary and the adjoining connective tissue area. Am J Anat 118:785-810.
44. Lee FC, Tilghmanm RC. 1933. Lymph vessels in rabbit carcinoma, with a note on the normal lymph vessel structure of the testis. Arch Surg 26:602-616.
45. Lee J, Gray A, Yuan J, Luoh SM, Avraham H, Wood WI. 1996. Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. Proc Natl Acad Sci USA 93:1988-1992.
46. Leu AJ, Berk DA, Lymboussaki A, Alitalo K, Jain RK. 2000. Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res 60:4324-4327.
47. Liotta LA, Steeg PS, Stetler-Stevenson WG. 1991. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64:327-336.
48. Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R, Banerji S, Huarte J, Montesano R, Jackson DG, Orci L, Alitalo K, Christofori G, Pepper MS. 2001. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 20:672-682.
49. Marchetti C, Poggi P, Piacentini C, Calligaro A. 1991. Scanning and transmission electron microscopy of rabbit heart lymphatic capillaries. Lymphology 24:26-31.
50. McGeown JG, McHale NG, Thornbury KD. 1988. Effects of varying patterns of external compression on lymph flow in the hindlimb of the anaesthetized sheep. J Physiol Lond 397:449-457.
51. McHale NG, Thornbury KD. 1989. The effect of anesthetics on lymphatic contractility. Microvasc Res 37:70-76.
52. McNeill GC, Witte MH, Witte CL, Williams WH, Hall JN, Patton DD, Pond GD, Woolfenden JM. 1989. Whole-body lymphangioscintigraphy: preferred method of initial assessment of the peripheral lymphatic system. Radiology 172:495-502.
53. Mislin H. 1976. Active contractility of the lymphangion and coordination of lymphangion chains. Experimentia Basel 32:820-822.
54. Mortimer PS, Simmonds R, Rezvani M, Robbins M, Hopewell JW, Ryan TJ. 1990. The measurement of skin lymph flow by isotope clearance - reliability, reproducibility, injection dynamics, and the effect of massage. J Invest Dermatol 95:677-682.
55. Negrini D, Ballard ST, Benoit JN. 1994. Contribution of lymphatic myogenic activity and respiratory movements to pleural lymph flow. J Appl Physiol 76:2267-2274.
56. Negrini D, Passi A, DeLuca G, Miserocchi G. 1996. Pulmonary interstitial pressure and proteoglycans during development of pulmonary edema. Am J Physiol 270:H2000-2007.
57. Niki T, Iba S, Tokunou M, Yamada T, Matsuno Y, Hirohashi S. 2000. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin Cancer Res 6:2431-2439.
58. Oh SJ, Jeltsch MM, Birkenhager R, McCarthy JE, Weich HA, Christ B, Alitalo K, Wilting J. 1997. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 188:96-109.
59. Ohhashi T, Azuma T, Sakaguchi M. 1980. Active and passive mechanical characteristics of bovine mesenteric lymphatics. Am J Physiol 239:H88-95.
60. Ohta Y, Shridhar V, Bright RK, Kalemkerian GP, Du W, Carbone M, Watanabe Y, Pass HI. 1999. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours. Br J Cancer 81:54-61.
61. Ohta Y, Nozawa H, Tanaka Y, Oda M, Watanabe Y. 2000. Increased vascular endothelial growth factor and vascular endothelial growth factor-c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 119:804-813.
62. Olszewski WL, Engeset A. 1980. Intrinsic contractility of prenodal lymph vessels and lymph flow in human leg. Am J Physiol 239: H775-H783.
63. Olszewski WL, Engeset A, Jaeger M, Sokolowski J, Theodorsen L. 1977. Flow and composition of leg lymph in normal men during venous stasis, muscular activity and local hyperthermia. Acta Physiol Scand 99:149-155.
64. Papoutsi M, Siemeister G, Weindel K, Tomarev SI, Kurz H, Schachtele C, Martiny-Baron G, Christ B, Marme D, Wilting J. 2000. Active interaction of human A375 melanoma cells with the lymphatics in vivo. Histochem Cell Biol 114:373-385.
65. Parsons RJ, McMaster PD. 1938. The effect of the pulse upon the formation and flow of lymph. J Exp Med 68:353-376.
66. Pullinger BD, Florey HW. 1935. Some observations on the structure and functions of lymphatics: their behavior in local edema. Br J Exp Pathol 16:49.
67. Reddy NP, Staub NC. 1981. Intrinsic propulsive activity of thoracic duct perfused in anesthetized dogs. Microvasc Res 21:183-192.
68. Reichert FL. 1926. The regeneration of the lymphatics. Arch Surg 13:871-881.
69. Renkin EM, Wiig H. 1994. Limits to steady-state lymph flow rates derived from plasma-to-tissue uptake measurements. Microvasc Res 47:318-328.
70. Salven P, Lymboussaki A, Heikkila P, Jaaskela-Saari H, Enholm B, Aase K, von Euler G, Eriksson U, Alitalo K, Joensuu H. 1998. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am J Pathol 153:103-108.
71. Schad H, Brechteisbauer H, Kramer K. 1976. Effect of anesthesia (Halothane) on thoracic duct lymph flow and lymph composition in dogs. Ergeb Angiol 12:185-189.
72. Schad H, Flowaczny H, Brechtelsbauer H, Birkenfeld G. 1978. The significance of respiration for thoracic duct flow in relation to other driving forces of lymph flow. Pfluegers Arch 378:121-125.
73. Schmid-Schönbein GW. 1990a. Mechanisms causing initial lymphatics to expand and compress to promote lymph flow. Arch Histol Cytol 53 Suppl:107-114.
74. Schmid-Schönbein GW. 1990b. Microlymphatics and lymph flow. Physiol Rev 70:987-1028.
75. Shushanov S, Bronstein M, Adelaide J, Jussila L, Tchipysheva T, Jacquemier J, Stavrovskaya A, Birnbaum D, Karamysheva A. 2000. VEGF-C and VEGFR3 expression in human thyroid pathologies. Int J Cancer 86:47-52.
76. Skobe M, Detmar M. 2000. Structure, function and molecular control of the skin lymphatic system. Rev J Invest Dermatol Symp Proceed 5:14-19.
77. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K, Detmar M. 2001a. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7:192-198.
78. Skobe M, Hamberg LM, Hawighorst T, Schirner M, Wolf GL, Alitalo K, Detmar M. 2001b. Concurrent induction of lymphangiogenesis, angiogenesis and macrophage recruitment by VEGF-C in melanoma. Am J Pathol, in press.
79. Stacker SA, Caesar C, Baldwin ME, Thornton GE, Williams RA, Prevo R, Jackson DG, Nishikawa S, Kubo H, Achen MG. 2001. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7:186-191.
80. Swartz MA, Berk DA, Jain RK. 1996. Transport in lymphatic capillaries. I. Macroscopic measurement using residence time distribution analysis. Am J Physiol 270:H324-329.
81. Tanigawa N, Kanazawa T, Satomura K, Hikasa Y, Hashida M, Muranishi S, Sezaki H. 1981. Experimental study on lymphatic vascular changes in the development of cancer. Lymphology 14:149-154.
82. Taylor AE, Gibson WH, Granger HJ, Guyton AC. 1973. The interaction between intracapillary and tissue forces in the overall regulation of interstitial fluid volume. Lymphology 6:192-208.
83. Tsurusaki T, Kanda S, Sakai H, Kanetake H, Saito Y, Alitalo K, Koji T. 1999. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br J Cancer 80:309-313.
84. Veikkola T, Karkkainen M, Claesson-Welsh L, Alitalo K 2000. Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res 60:203-212.
85. Weiss L, Schmid-Schönbein GW. 1989. Biomechanical interactions of cancer cells with the microvasculature during metastasis. Cell Biophys 14:187-215.
86. Wen S, Dorffler-Melly J, Herrig I, Schiesser M, Franzeck UK, Bollinger A. 1994. Fluctuation of skin lymphatic capillary pressure in controls and in patients with primary lymphedema. Int J Microcirc Clin Exp 14:139-143.
87. Weninger W, Partanen TA, Breiteneder-Geleff S, Mayer C, Kowalski H, Mildner M, Pammer J, Sturzl M, Kerjaschki D, Alitalo K, Tschachler E. 1999. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggests a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Lab Invest 79:243-251.
88. Wigle JT, Oliver G. 1999. Prox1 function is required for the development of the murine lymphatic system. Cell 98:769-778.
89. Witte MH, Way DL, Witte CL, Bernas M. 1997. Lymphangiogenesis: mechanisms, significance and clinical implications. EXS 79:65-112.
90. Witzenbichler B, Asahara T, Murohara T, Silver M, Spyridopoulos I, Magner M, Principe N, Kearney M, Hu JS, Isner JM. 1998. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am J Pathol 153:381-394.
91. Yoffey JM, Courtice FC. 1970. Lymphatics, lymph and the lymphomyeloid complex. London: Academic Press.
92. Yonemura Y, Endo Y, Fujita H, Fushida S, Ninomiya I, Bandou E, Taniguchi K, Miwa K, Ohoyama S, Sugiyama K, Sasaki T. 1999. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res 5:1823-1829.
93. Zaugg-Vesti B, Dorffler-Melly J, Spiegel M, Wen S, Franzeck UK, Bollinger A. 1993. Lymphatic capillary pressure in patients with primary lymphedema. Microvasc Res 46:128-134.
94. Zawieja DC, Davis KL, Schuster R, Hinds WM, Granger HJ. 1993. Distribution, propagation, and coordination of contractile activity in lymphatics. Am J Physiol 264:H1283-1291.
95. Zeidman I, Copeland BE, Warren S. 1955. Experimental studies on the spread of cancer in the lymphatic system. II. Absence of a lymphatic supply in carcinomas. Cancer 8:123-127.
96. Zetter BR. 1993. Adhesion molecules in tumor metastasis. Semin Cancer Res 4:219-229.